5 results
rheumatology management druginduced systemic activation comparison differential dil hematology macrophage mas medications pharmacology risk summary syndrome table
Systemic Lupus Erythematosus (SLE) - Diagnosis and Management Summary • Epidemiology: 10-180/100,000, Typically Age 20-40, F:M
Systemic Lupus Erythematosus ... (SLE) - Diagnosis ... life-threatening • Treatment ... • Evolution: ... #Erythematosus
Drug Induced Lupus vs SLE Drug Induced Lupus (DIL): • Epidemiology: -10% of all lupus cases, drug-dependent,
Drug Induced Lupus ... vs SLE Drug Induced ... Erythematosus ( ... life-threatening • Treatment ... #rheumatology #diagnosis
Drug Induced Systemic Lupus Erythematosus > 100 drugs have been associated with drug-induced SLE High risk (>5%): •
Lupus Erythematosus ... SLE High risk ... for 1 year of treatment ... #Erythematosus ... #differential #diagnosis
Macrophage Activation Syndrome (MAS) Classified among the secondary or acquired forms of haemophagocytic lymphohistiocytosis (sHLH) What? A subset of
erythematosus ... SLE], AOSD) • Infection ... ) • Sepsis • Drug-induced ... Treatment: • Corticosteroids ... Activation #Syndrome #Diagnosis
Drug Induced Lupus (DIL) • Epidemiology: -10% of all lupus cases, drug-dependent, 4:1 to 1:1 F:M
Drug Induced Lupus ... is rare in DIL, SCLE-DIL ... cutaneous-DIL • Evolution ... #rheumatology #diagnosis ... #treatment #management
No results found for "HairCell path treatment evaluation lupus cardiology diagnosis erythematosus sle drugs"
Try removing search terms or sorting by relevance
Or Upload an image for you and others searching for #HairCell #path #treatment #evaluation #lupus #cardiology #diagnosis #erythematosus #sle #drugs